Article
Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis
1 Jan 2010
Abstract excerpt
In this review, I first provide relevant background information about normal epidermal barrier structure and function. I then update recent information about how inherited defects in either filaggrin and/or in the serine protease inhibitor, lymphoepithelial Kazal-type inhibitor 1, converge to stimulate the development of atopic dermatitis (AD). Next I explain the multiple mechanisms whereby a primary barrier...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
